News-MedicalStem cells show promise in preventing post-heart attack heart failurePatients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds a clinical trial published by The BMJ today.news-medical.netStem-cell heart patch (BioVAT) raised ejection fraction at 3 months in phase 1-2 trial
Louis shares a NEJM interim report of a phase 1-2 trial in which stem-cell-derived engineered tissue was placed on the surface of failing human hearts. At 3 months it was associated with thicker target heart wall, higher ejection fraction and better quality-of-life scores, though every patient had at least one adverse event and longer follow-up is needed.

